Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 1,501–1,525 of 27,380 studies, newest first · page 61 of 1096.

March 2026 25

  1. 2026-03-27

    Long-term impact of disclosing amyloid PET results to individuals with subjective cognitive decline

    ✓ Peer-reviewed Biomarkers Alzheimer s Research & Therapy

    Key finding: Participants’ motivations for testing and long-term adaptation to the results were strongly shaped by cognitive concerns and personal experiences of dementia in relatives. +4 more findings

  2. 2026-03-27

    Medicaid Home and Community-Based Services Initiation and Acute Services Use

    ✓ Peer-reviewed Health systems and care delivery JAMA Health Forum

    Key finding: In a sample of 1218 new HCBS users (75% female, 77% Black; mean [SD] age, 70.5 [7.5] years), Medicaid HCBS initiation was associated with a decrease in probability of ED use (-2.70 percentage points; 95% CI, -4.18 to -1.22 percentage points) and a decrease in probability of inpatient discharge (-2.63 percentage points; 95% CI, -3.75 to -1.51 percentage points). +4 more findings

  3. 2026-03-27
  4. 2026-03-26

    Dementia Burden and Modifiable Risk Factors in Type 2 Diabetes: Population Based, Prospective Cohort Study

    ✓ Peer-reviewed Risk factors Diabetes Obesity and Metabolism

    Key finding: T2D was associated with a higher risk and earlier onset of dementia, especially in cases with T2D diagnosed at ages 30-54 years. +4 more findings

  5. 2026-03-25

    The role of mitochondria in Alzheimer's disease

    ✓ Peer-reviewed Risk genes beyond APOE Zenodo (CERN European Organization for Nuclear Research)

    Key finding: The 18 kDa translocator protein (TSPO), a neuroinflammation protein expressed by glial and endothelial cells.Aβ40 and 42 soluble and insoluble will also be quantified, they are involved in the physiology of the human body and in Alzheimer’s disease forAβ42.Aβ total and Tau will be analyzed. +4 more findings

  6. 2026-03-25

    The role of mitochondria in Alzheimer's disease

    ✓ Peer-reviewed Risk genes beyond APOE Zenodo (CERN European Organization for Nuclear Research)

    Key finding: The 18 kDa translocator protein (TSPO), a neuroinflammation protein expressed by glial and endothelial cells.Aβ40 and 42 soluble and insoluble will also be quantified, they are involved in the physiology of the human body and in Alzheimer’s disease forAβ42.Aβ total and Tau will be analyzed. +4 more findings

  7. 2026-03-24

    Locus coeruleus TDP-43 pathology in a community-based cohort: Clinical and pathological correlates

    ✓ Peer-reviewed Brain tissue and pathology Journal of Neuropathology & Experimental Neurology

    Key finding: In terms of clinical-pathological correlations, LC pTDP-43 pathology was associated with depressive symptoms but not with global cognition or with other BPSDs. +1 more finding

  8. 2026-03-24

    A quantitative cell-based reporter links TDP-43 aggregation and dysfunction to define pathogenic mechanisms

    ✓ Peer-reviewed Brain tissue and pathology PLoS Biology

    Key finding: Together, these findings reveal a molecularly guided strategy to directly impact TDP-43 activity by decreasing its misfolding and aggregation, highlighting approaches to prevent TDP-43 dysfunction and mitigate toxicity under pathological conditions.

  9. 2026-03-24

    Blood level of β-amyloid, Tau, and p-Tau in mild cognitive impairment and Alzheimer disease: A follow up study

    ✓ Peer-reviewed Mild cognitive impairment The Indian Journal of Medical Research

    Key finding: Comparison of proteins between the three groups revealed significantly lower Aβ1-42, higher Tau and pTau protein expression in serum of patients with Alzheimer disease as compared to patients with mild cognitive impairment and controls. +3 more findings

  10. 2026-03-24

    Mapping Caregiver Needs to AI Chatbot Design: Strengths and Gaps in Mental Health Support for Alzheimer's and Dementia Caregivers

    ✓ Peer-reviewed Caregiving ACM Transactions on Computing for Healthcare

    Key finding: Family caregivers of individuals with Alzheimer’s Disease and Related Dementia (AD/ADRD) face significant emotional and logistical challenges that place them at heightened risk for stress, anxiety, and depression. +1 more finding

  11. 2026-03-23

    Single-Cell Transcriptomic Identification of SYK Kinase as a Therapeutic Target in Disease-Associated Microglia for Alzheimer's Disease Treatment

    ✓ Peer-reviewed Risk genes beyond APOE Zenodo (CERN European Organization for Nuclear Research)

    Key finding: ChEMBL screening across 8 microglial DAM-relevant targets identified 6,230 NOVEL_ALL inhibitor candidates. +4 more findings

  12. 2026-03-23

    Single-Cell Transcriptomic Identification of SYK Kinase as a Therapeutic Target in Disease-Associated Microglia for Alzheimer's Disease Treatment

    ✓ Peer-reviewed Risk genes beyond APOE Zenodo (CERN European Organization for Nuclear Research)

    Key finding: ChEMBL screening across 8 microglial DAM-relevant targets identified 6,230 NOVEL_ALL inhibitor candidates. +4 more findings

  13. 2026-03-22
  14. 2026-03-22

    Neuropathological measures of increased tau phosphorylation across the Down syndrome lifespan

    ✓ Peer-reviewed Down syndrome and Alzheimer's Acta neuropathologica

    Key finding: Individuals with Down syndrome (DS) have an increased risk of developing Alzheimer disease (AD), with nearly all individuals exhibiting AD neuropathology, including amyloid beta (Aβ) plaques and neurofibrillary tangles (NFT), by age 40 years. +4 more findings

  15. 2026-03-21

    Comprehensive single-cell transcriptomic atlas of microglia in Alzheimer's disease mouse models

    ✓ Peer-reviewed Genetics Molecular psychiatry

    Key finding: Here, we constructed a comprehensive Mouse Microglia Atlas (MoMicA) to resolve conserved subtypes, delineate dynamic trajectories, and identify key regulators associated with AD pathology.

  16. 2026-03-21

    How does Australian primary care face dementia? Identifying current practice and barriers in dementia diagnosis and management in Australian primary care – a qualitative interview study

    ✓ Peer-reviewed Getting a diagnosis BMC Family Practice

    Key finding: Four themes described current primary care practitioner practices in dementia diagnosis and management (1) Family concern triggers dementia investigation (2) GPs delay conversations about dementia (3) Completing routine cognitive assessments in the 75+ health assessment, and (4) Variability in post-diagnostic care. +3 more findings

  17. 2026-03-21

    Redirection Hypothesis Alzheimers

    ✓ Peer-reviewed Biomarkers Zenodo (CERN European Organization for Nuclear Research)

    Key finding: The most successful amyloid-targeting treatments achieve modest plaque reduction with marginal clinical benefit and significant adverse effects.

  18. 2026-03-21

    Redirection Hypothesis Alzheimers

    ✓ Peer-reviewed Biomarkers Zenodo (CERN European Organization for Nuclear Research)

    Key finding: The most successful amyloid-targeting treatments achieve modest plaque reduction with marginal clinical benefit and significant adverse effects.

  19. 2026-03-20

    Real-world implementation of lecanemab and donanemab in an Italian memory center: a 1-year experience

    ✓ Peer-reviewed Biomarkers Alzheimer's research & therapy

    Key finding: In donanemab-treated patients, mildly symptomatic ARIA-E occurred in 10% (2/20) and asymptomatic ARIA-H in 15% (3/20). +4 more findings

  20. 2026-03-20

    Frequent in dementia, deadliest without it: delirium and mortality in hospitalised older adults

    ✓ Peer-reviewed Clinical safety Age and Ageing

    Key finding: Among 2556 patients (mean age 79 ± 9 years; 56% women), delirium occurred in 957 (37%). +4 more findings

  21. 2026-03-20

    The Benson Complex Figure Test for the Differential Diagnosis of Dementias

    ✓ Peer-reviewed Cognitive tests and assessment NeuroSci

    Key finding: Multinomial logistic regression, adjusted for age, sex, and education, revealed distinct BCFT profiles across dementia subtypes. +3 more findings

  22. 2026-03-20

    Association between zinc deficiency and adverse outcomes in patients with dementia: a matched cohort study

    ✓ Peer-reviewed How common it is Frontiers in Nutrition

    Key finding: In this observational study, zinc deficiency was associated with increased 1-year mortality and infection-related complications in patients with dementia, with evidence of a dose–response relationship. +4 more findings

  23. 2026-03-20
  24. 2026-03-19
  25. 2026-03-19

    Association of the Big Five personality traits with cognitive decline: a 24-week multidomain intervention study

    ✓ Peer-reviewed Prevention trials Frontiers in Psychiatry

    Key finding: Among the five personality domains, only extraversion was significantly associated with reduced odds of cognitive decline within the intervention group over 24 weeks (fully adjusted model: OR = 0.35; 95% CI: 0.15-0.82). +1 more finding

Browse the library by subject, with the full score breakdown →